XORTX Therapeutics Inc.
XRTX
$0.88
$0.011.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -587.00K | 170.10K | -3.02M | 2.70M | -1.33M |
| Total Depreciation and Amortization | 25.90K | 33.00K | 32.10K | 24.40K | 16.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -247.50K | -1.60M | 2.01M | -3.61M | 24.00K |
| Change in Net Operating Assets | 56.70K | 659.20K | -326.90K | -412.20K | 222.20K |
| Cash from Operations | -751.90K | -736.50K | -1.30M | -1.30M | -1.07M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.20K | -9.10K | -2.60K | -9.80K | -7.30K |
| Cash from Investing | -23.20K | -9.10K | -2.60K | -9.80K | -7.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.20K | -8.90K | -15.90K | -17.00K | -16.70K |
| Issuance of Common Stock | 0.00 | 0.00 | 2.02M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -297.60K | -295.30K | -- |
| Cash from Financing | -22.20K | -8.90K | 1.70M | -312.30K | -16.70K |
| Foreign Exchange rate Adjustments | 19.50K | -2.50K | -9.30K | -1.50K | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -777.70K | -757.00K | 387.80K | -1.62M | -1.09M |
